Kite, a Gilead Company, today announced the U.S. Food and Drug Administration approved an update to the Yescarta ® prescribing information removing the previous Limitations of Use in patients with ...

– Limitations of Use Removed for Rare and Aggressive Form of non-Hodgkin Lymphoma Based on Manageable Safety Profile with No New Safety Signals Identified – SANTA MONICA, Calif., February 06, ...

After rolling out account verification for brands and individual users, Reddit CEO Steve Huffman writes in a letter to shareholders that the platform is trying to make it easier to identify bots, too.

Canada’s immigration department has issued another round of invitations under Express Entry, continuing its early-2026 pattern of prioritising candidates with strong in-Canada links. Immigration, ...

Elon Musk’s X is the latest social network to roll out a feature to label edited images as “manipulated media,” if a post by Elon Musk is to be believed. But the company has not clarified how it will ...

FDA-cleared labeling supports broad clinical applicability, including Donation after Circulatory Death (DCD) donors, and positions VitaSmart™ as a scalable and economically compelling platform for U.S ...

A group of recreational cannabis flower products purchased in October at Brilliant Buds in Bethel were fully compliant with state requirements. The stickers for the “Find.” brand products displayed ...

The DWS60 Draw Wire encoder system provides linear motion feedback over long distances for a range of industrial applications. Key features include an extended measurement range capable of measuring ...

A new certification for deforestation-free beef in Brazil, the first of its kind, aims to bring more transparency to existing protocols for monitoring deforestation in meat supply chains. The ...

“A little Pete Murray” crept into the Urban Dictionary this year to describe feeling a bit rough after a big night because you’ve “seen better days.” The clever quip was inspired by his 2005 smash hit ...

Health care affordability is likely to be a defining issue of the 2026 midterms as Democrats hope to retake control of the House of Representatives and Senate. It may be particularly salient if ...